| 12.61 Data as of May 21 |  +0.18 / +1.45%Today’s Change | 3.91 Today|||52-Week Range 14.09 | +87.93% Year-to-Date |
| Previous close | 12.43 |
| Today’s open | 12.43 |
| Day’s range | -- - -- |
| Volume | 912,511 |
| Average volume (3 months) | 1,803,023 |
| Market cap | $1.0B |
| Dividend yield | -- |
| Earnings growth (last year) | +9.73% |
| Earnings growth (this year) | +8.33% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +20.91% |
| P/E ratio | NM |
| Price/Sales | 34.57 |
| Price/Book | 8.47 |
| Today’s change | Today’s % change | |
|---|---|---|
| MGMistras Group Inc | +0.14 | +0.67% |
| NEONeogenomics Inc | -0.13 | -3.54% |
| FCSCFibrocell Science In... | -0.02 | -0.42% |
| CVDCovance Inc | -0.36 | -0.47% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $11.2M |
| Annual profit (last year) | -$59.1M |
| Net profit margin | -527.79% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Anthony S. Marucci, MBA |
CFO, Secretary, Treasurer & Senior Vice President Avery W. Catlin, MBA, CPA |
Corporate headquarters Needham, Massachusetts |
.
